Cervical cancer usually does not cause symptoms until it is advanced. A new guideline makes it easier to detect when ...

The National Institute for Health and Care Excellence (NICE) has recommended funding for advanced cervical cancer treatment with immunotherapy, representing the first new life-extending NHS treatment ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Adding ...

January is Cervical Cancer Awareness Month, and research shows that late-stage cervical cancer appears to be on the rise. Dr. Robert DeBernardo with Cleveland Clinic said that could be due in part to ...

PIK3CA and ARID1A may be targets for drug development in recurrent or metastatic cervical cancer, according to research presented at the recent Society of Gynecologic Oncology (SGO) annual meeting. It ...

Background: Globally, cervical cancer primarily affects socially disadvantaged women. Five randomized trials were the foundation for adopting cisplatin-based chemotherapy during radiation as the ...

You may have heard about HPV testing and self-swabbing to collect the sample. Does that work as well? Here are the ins and outs of this newer option.

Tisotumab vedotin-tftv prolonged OS compared with chemotherapy alone among women with recurrent or metastatic cervical cancer, according to the agent’s manufacturers. Tisotumab vedotin-tftv (Tivdak; ...

The Food and Drug Administration (FDA) has recently approved Keytruda (pembrolizumab) plus chemoradiotherapy for the treatment of patients with stages 3 to 4A cervical cancer. The recent approvalof ...

Advanced cervical cancer remains a formidable clinical challenge, particularly in patients with locally advanced or recurrent disease. Over recent years, therapeutic strategies have evolved from ...